Philips Dives Deeper Into Patient Monitoring with SmartQare Partnership

Philips PHG is on a relentless quest to fortify its patient monitoring solutions hub through strategic collaborations.
Partnering with smartQare, the company aims to seamlessly integrate the viQtor solution into its clinical patient monitoring platforms, fostering continuous patient monitoring ubiquitously, whether in hospitals or beyond.
This step ensures enhanced communication between sensors and systems, rendering data and decision support readily accessible via user-friendly platforms.
Moreover, as part of this synergistic initiative, smartQare will acquire Philips’ Healthdot business, amalgamating its viQtor patient monitoring solution with Philips’ wearable biosensors, ushering in integrated remote monitoring for healthcare providers and patients alike.
Philips stands to gain substantial traction across a spectrum of healthcare institutions, propelled by this groundbreaking collaboration.

Enhancing Patient Monitoring Solutions

Apart from the smartQare alliance, Philips recently introduced Philips Capsule Surveillance to reinforce its patient monitoring solutions armory.
This system delivers a holistic patient status overview, facilitating personalized alerts and decision-making, mitigating cognitive overload challenges in intricate hospital settings.
In addition, Philips unveiled the Visual Patient Avatar, a novel monitoring solution designed to aid clinicians in operation theaters grappling with complex patient data and time constraints.
This innovative solution aims to enhance situational awareness in operating rooms by visualizing vital patient information through animations, colors, and shapes. The intuitive avatar display improves data recall and processing, potentially saving lives and offering clinical staff peace of mind.
Moreover, Philips obtained 510(k) clearance for its IntelliVue patient monitor software, inclusive of the award-winning Philips Sounds alarm package, expanding its availability to the United States and over 200 countries globally. This move sets the stage for creating a serene, healing atmosphere for both patients and caregivers.

Conclusion

The suite of initiatives undertaken is poised to pave the way for Philips to harness the growth potential inherent in the worldwide patient monitoring solutions market. According to a Vynz Research report, the global patient monitoring solutions arena is anticipated to balloon to $38.95 billion, denoting a CAGR of 7.8% during the projected span from 2023 to 2030.
Moreover, the fortified patient monitoring solutions portfolio is expected to buoy the Connected Care division, ultimately bolstering the overall financial performance of the company moving forward.
Philips has set its sights on achieving 3-5% comparable sales growth in 2024.
The Zacks Consensus Estimate for 2024 sales is tabbed at $20.12 billion, marking a 2.4% upswing from the preceding year’s quarter.

Zacks Rank & Companies to Explore

At present, Philips holds a Zacks Rank #3 (Hold).
The company’s shares have dipped by 13.9% in the year-to-date period, lagging behind the 4.2% growth witnessed in the Zacks Medical sector.
Some more promising options in the broader medical market domain encompass DaVita DVA, Cardinal Health CAH, and AdaptHealth AHCO. While DaVita flaunts a Zacks Rank #1 (Strong Buy) presently, Cardinal Health and AdaptHealth carry a Zacks Rank #2 (Buy) each.
DaVita’s shares have surged by 27.5% in the year-to-date period, with a projected long-term earnings growth rate of 12.15%.
Cardinal Health’s shares have gained 9% year-to-date, and the company currently boasts a long-term earnings growth rate projection of 14.25%.
AdaptHealth’s shares have soared by 43.6% in the year-to-date period, with a long-term earnings growth rate forecast of 14.90%.

To read this article on Zacks.com click here.